FLOXIN I.V. LIQ 20MG/ML 20 MG
OFLOXACIN : 20 MG · DIN 02049414 · ORTHO PHARMACEUTICAL, DIVISION OF JANSSEN-ORTHO INC.
Health Canada status: CANCELLED PRE MARKET
What is FLOXIN I.V. LIQ 20MG/ML?
FLOXIN I.V. LIQ 20MG/ML 20 MG contains OFLOXACIN : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02049414, held by ORTHO PHARMACEUTICAL, DIVISION OF JANSSEN-ORTHO INC., supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as cancelled pre market, status dated 13-Aug-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02049414 |
|---|---|
| Brand name | FLOXIN I.V. LIQ 20MG/ML |
| Generic / active ingredient | OFLOXACIN : 20 MG |
| Manufacturer | ORTHO PHARMACEUTICAL, DIVISION OF JANSSEN-ORTHO INC. |
| Strength | 20 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS |
| ATC code | J01MA01 OFLOXACIN |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 13-Aug-1996 |
What can be used instead?
Other Canadian products sharing ATC code J01MA01 OFLOXACIN. 0 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLOXIN TABLETS 200MG | 200 MG | TABLET | JANSSEN INC | CANCELLED POST MARKET | DIN 01968424 |
| FLOXIN TABLETS 300MG | 300 MG | TABLET | JANSSEN INC | CANCELLED POST MARKET | DIN 01968416 |
| FLOXIN TABLETS 400MG | 400 MG | TABLET | JANSSEN INC | CANCELLED POST MARKET | DIN 01968408 |
| NOVO-OFLOXACIN | 200 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02243474 |
| NOVO-OFLOXACIN | 300 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02243475 |
| NOVO-OFLOXACIN | 400 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02243476 |
| OFLOXACIN TABLETS | 200 MG | TABLET | AA PHARMA INC | CANCELLED POST MARKET | DIN 02231529 |
| OFLOXACIN TABLETS | 300 MG | TABLET | AA PHARMA INC | CANCELLED POST MARKET | DIN 02231531 |
| OFLOXACIN TABLETS | 400 MG | TABLET | AA PHARMA INC | CANCELLED POST MARKET | DIN 02231532 |
Who else supplies OFLOXACIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OFLOXACIN appears in 40 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.